Revenue and Profitability - The company's revenue for Q3 2025 was ¥305,842,291.31, a decrease of 27.95% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥13,414,212.15, an increase of 80.77% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥187,810.37, a decline of 105.76% compared to the previous year[5] - Total operating revenue for the current period was ¥1,093,873,651.93, a decrease of 9.9% from ¥1,214,136,418.29 in the previous period[17] - Net profit for the current period was ¥58,824,153.56, a decline of 32.6% compared to ¥87,272,527.89 in the previous period[19] Earnings Per Share - Basic and diluted earnings per share for Q3 2025 were both ¥0.11, an increase of 87.87% year-on-year[5] - Basic earnings per share for the current period was ¥0.38, down from ¥0.59 in the previous period[19] - The diluted earnings per share for the current period is 0.38, compared to 0.59 in the previous period[20] Cash Flow - The operating cash flow net amount for the year-to-date period reached ¥206,751,560.94, a significant increase of 796.38%[5] - The net cash flow from operating activities for the first nine months of 2025 was significantly improved, rising from ¥23,065,087.79 to ¥206,751,560.94[8] - Cash inflow from operating activities totaled ¥1,526,507,831.65, an increase of 37.4% from ¥1,110,538,853.79 in the previous period[20] - The net cash flow from operating activities is ¥206,751,560.94, significantly up from ¥23,065,087.79 in the previous period[20] - Cash outflow from investment activities reached ¥2,538,798,875.08, compared to ¥1,944,148,050.89 in the previous period, resulting in a net cash flow from investment activities of -¥556,260,092.62[21] - Cash inflow from financing activities was ¥707,100,913.26, an increase from ¥672,465,520.70 in the previous period[21] - The net cash flow from financing activities improved to ¥286,998,545.55 from ¥82,248,861.49 in the previous period[21] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥3,494,554,578.48, reflecting a 0.99% increase from the end of the previous year[5] - The company's equity attributable to shareholders increased by 1.86% to ¥2,161,545,266.30 compared to the end of the previous year[5] - The company's total assets increased to ¥3,494,554,578.48, up from ¥3,460,279,665.56, reflecting a growth of 1.0%[17] - Total liabilities decreased to ¥1,234,422,840.80 from ¥1,252,432,403.36, a reduction of 1.4%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,744, with no preferred shareholders having restored voting rights[9] - Jiangsu Shangkun Biological Equipment Co., Ltd. held 29.08% of shares, amounting to 34,890,248 shares, making it the largest shareholder[9] - The company reported a total of 70,347,000 restricted shares at the beginning of the period, with 24,342,564 shares released during the period[12] Investment and Expenses - The company experienced a 23.46% increase in fixed assets, amounting to ¥742,945,709.09 as of September 30, 2025[8] - The fixed assets increased to 742,945,709.09 from 601,782,026.25, reflecting ongoing investments in property and equipment[15] - The company’s long-term equity investments were reported at 40,000,000.00, indicating a strategic focus on long-term growth[15] - Research and development expenses were ¥51,065,297.06, a decrease of 11.3% from ¥57,588,177.15[17] - The company reported an investment income of ¥14,180,211.34, an increase from ¥8,007,368.21 in the previous period[19] Cash and Equivalents - The cash and cash equivalents at the end of the period were 709,614,994.19, down from 880,380,086.42 at the beginning of the period[15] - The total current assets decreased to 2,341,881,763.87 from 2,517,288,396.14, indicating a decline in liquidity[15] - The ending balance of cash and cash equivalents is ¥543,986,703.65, slightly up from ¥543,223,872.96 in the previous period[21] - The company received ¥17,268,358.56 in tax refunds, up from ¥8,469,096.83 in the previous period[20] - The company reported cash received from sales of goods and services of ¥1,224,286,913.99, an increase from ¥1,063,079,018.45 in the previous period[20] Comprehensive Income - Other comprehensive income after tax was -¥45,091.69, compared to -¥792,488.54 in the previous period[19]
通灵股份(301168) - 2025 Q3 - 季度财报